3,0
2 feb 2011
Dipendente attuale
New York, NY
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Good pipeline, well-known company, good "starting point" for pharma. Novartis teaches you fundamental sales skills you need to learn and sell.
Svantaggi
Cardiovascular portfolio puts teammates in competition with one another. Diovan going off patent in 2012- because of this there is a lull in the pipeline, it will pick up again in 2013 and beyond.